Is It Too Late To Consider Argan (AGX) After A 10x Five Year Run?

• If you are wondering whether Argan at around US$566 per share still offers value after a strong run, you are not alone.
• The stock has posted returns of 19.6% over the last week, 25.6% over the last month, 73.8% year to date and 313.5% over the past year, with a very large 3-year gain and a 10x return over 5 years.
• Recent coverage has focused on Argan's sharp share price performance and what it might imply for expectations already baked into the stock. Investors are now weighing whether these moves reflect a change in perceived risk, an adjustment to previous pessimism, or simply enthusiasm running ahead of fundamentals.
• Against that backdrop, Argan currently holds a valuation score of 0/6. The key question is how different valuation approaches line up with this score and whether there is an even richer way to think about value that will be covered later in the article.

Argan scores just 0/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.

Approach 1: Argan Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow model estimates what a company could be worth by projecting its future cash flows and discounting them back to today using a required return. For Argan, the model used is a 2 Stage Free Cash Flow to Equity approach based on cash flow projections.

Argan's latest twelve month Free Cash Flow is $409.5 million. Analyst and extrapolated projections for the next decade range from around $110.6 million to $263.4 million a year, with Simply Wall St extending estimates beyond the typical 5 year analyst window. By 2035, the model is using an extrapolated Free Cash Flow figure of $263.4 million, with each year discounted back to present value in dollars.

When these cash flows are added up, the DCF suggests an estimated intrinsic value of about $282.18 per share. Compared with the current share price of around $566, the model implies the stock is 100.8% overvalued.

Result: OVERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Argan may be overvalued by 100.8%. Discover 62 high quality undervalued stocks or create your own screener to find better value opportunities.

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Argan.

Approach 2: Argan Price vs Earnings

For profitable companies, the P/E ratio is a useful shortcut because it links what you pay for the stock to the earnings the business is already generating. It also reflects what the market is willing to pay for each dollar of earnings, which is where expectations and risk come in.

Higher expected earnings growth and lower perceived risk usually justify a higher P/E, while lower growth and higher risk tend to support a lower, more conservative P/E. Argan is currently trading on a P/E of 57.36x. That sits well above the Construction industry average of 34.01x and the peer average of 32.76x.

Simply Wall St’s Fair Ratio for Argan is 38.02x. This is a proprietary estimate of what Argan’s P/E might be, given factors such as its earnings growth profile, industry, profit margins, market cap and company specific risks. Because it adjusts for these elements, the Fair Ratio can be more informative than a simple comparison with peers or the broader industry.

Comparing Argan’s current P/E of 57.36x with the Fair Ratio of 38.02x suggests the market price is well above this tailored benchmark.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.

Upgrade Your Decision Making: Choose your Argan Narrative

Earlier it was mentioned that there is an even better way to understand valuation. Narratives on Simply Wall St give you a clear story behind the numbers by linking your view of Argan’s business, revenue, earnings and margin outlook to a forecast, a Fair Value and then a simple comparison with the current price. This is all within an easy tool on the Community page that updates when new results or news arrive. It already hosts very different Argan views, such as a higher Fair Value around US$550 with revenue of about US$1.9b and earnings of US$305.4m by 2029, compared with a lower Fair Value around US$284.68 with more moderate assumptions, so you can see where you sit between the most optimistic and more cautious investors.

Do you think there's more to the story for Argan? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com